Claudin18.2 expression and clinicopathological features in cytology effusion specimens from gastric adenocarcinoma: A comparative study with tissue specimens
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22688
Abstract: Zolbetuximab (IMAB362) is under investigation for treating advanced gastrointestinal tumors because it targets Claudin18.2 (CLDN18.2). CLDN18.2 is a promising molecule along with the presence of human epidermal growth factor receptor 2 in gastric cancer. This… read more here.
Keywords: expression; clinicopathological features; cytology; claudin18 expression ... See more keywords